Agilent Technologies Inc
NYSE:A
Intrinsic Value
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. [ Read More ]
The intrinsic value of one A stock under the Base Case scenario is 118.49 USD. Compared to the current market price of 133.91 USD, Agilent Technologies Inc is Overvalued by 12%.
Valuation Backtest
Agilent Technologies Inc
Run backtest to discover the historical profit from buying and selling A stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Agilent Technologies Inc
Current Assets | 4.3B |
Cash & Short-Term Investments | 1.7B |
Receivables | 1.3B |
Other Current Assets | 1.3B |
Non-Current Assets | 6.6B |
Long-Term Investments | 170m |
PP&E | 1.5B |
Intangibles | 4.4B |
Other Non-Current Assets | 561m |
Current Liabilities | 1.6B |
Accounts Payable | 488m |
Accrued Liabilities | 607m |
Other Current Liabilities | 522m |
Non-Current Liabilities | 3.1B |
Long-Term Debt | 2.6B |
Other Non-Current Liabilities | 588m |
Earnings Waterfall
Agilent Technologies Inc
Revenue
|
6.7B
USD
|
Cost of Revenue
|
-3.3B
USD
|
Gross Profit
|
3.4B
USD
|
Operating Expenses
|
-2.1B
USD
|
Operating Income
|
1.3B
USD
|
Other Expenses
|
-75m
USD
|
Net Income
|
1.2B
USD
|
Free Cash Flow Analysis
Agilent Technologies Inc
What is Free Cash Flow?
A Profitability Score
Profitability Due Diligence
Agilent Technologies Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Score
Agilent Technologies Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
A Solvency Score
Solvency Due Diligence
Agilent Technologies Inc's solvency score is 76/100. The higher the solvency score, the more solvent the company is.
Score
Agilent Technologies Inc's solvency score is 76/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
A Price Targets Summary
Agilent Technologies Inc
According to Wall Street analysts, the average 1-year price target for A is 151.87 USD with a low forecast of 128.27 USD and a high forecast of 173.25 USD.
Ownership
A Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
A Price
Agilent Technologies Inc
Average Annual Return | 20.69% |
Standard Deviation of Annual Returns | 19.2% |
Max Drawdown | -43% |
Market Capitalization | 39.2B USD |
Shares Outstanding | 294 000 000 |
Percentage of Shares Shorted | 1.52% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. The company is headquartered in Santa Clara, California and currently employs 17,200 full-time employees. The firm operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets business provides application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics business includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. Its Agilent CrossLab business spans the entire lab with its range of services portfolio, which is designed to improve customer outcomes. Its product categories include liquid chromatography (LC) systems and components, atomic absorption (AA) instruments and others.
Contact
IPO
Employees
Officers
The intrinsic value of one A stock under the Base Case scenario is 118.49 USD.
Compared to the current market price of 133.91 USD, Agilent Technologies Inc is Overvalued by 12%.